Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones

BACKGROUND: It is well accepted that the immune system efficiently contributes to positive outcomes of chemotherapeutic cancer treatment by activating immunogenic cell death (ICD). However, only a limited number of ICD-inducing compounds are well characterized at present; therefore, identification o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Fangtian, Shen, Peiliang, Ma, Yue, Ma, Wangbo, Wu, Hongyan, Liu, Hao, An, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194247/
https://www.ncbi.nlm.nih.gov/pubmed/34112202
http://dx.doi.org/10.1186/s12950-021-00289-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194247/
https://www.ncbi.nlm.nih.gov/pubmed/34112202
http://dx.doi.org/10.1186/s12950-021-00289-1

Ejemplares similares